Dr. Lal PathLabs Limited today announced the launch of the Sovaaka Diagnostic Experience Centre in Gurugram, marking a major step in the evolution of preventive healthcare in India. The launch was graced by Haryana Chief Minister Nayab Singh...
Torrent Pharma approves Rs 12,500 crore NCD issue to boost liquidity, fund acquisitions and capex, while maintaining strong balance sheet, low leverage, and long-term growth focus.
Bristol Myers Squibb positions India as a growth engine, investing in AI-led pharma commercialization, pipeline expansion, and faster market adoption across oncology and cardiology.
India pharma partnerships in 2025 are accelerating innovation, patient care, digital transformation, and market leadership through strategic alliances across R&D, tech, and supply chains.
Emcure Pharmaceuticals has announced a nationwide rollout of its obesity drug Poviztra, marking a focused push into India’s expanding weight-management market. The company plans to move beyond a metro-centric strategy and build demand across Tie...
Novartis is also rapidly increasing its business footprint in India making India its biggest global R&D center outside Switzerland. The Swiss firm has a workforce exceeding 9,000 employees in Hyderabad and Mumbai. This is a significant change...
Akums launches an enhanced Gabapentin ER for postherpetic neuralgia, using sustained-release technology to improve pain control, once-daily dosing and patient adherence in India.
GSK Nucala has moved a step closer to European approval after the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended the drug for adults with uncontrolled COPD marked by raised blood eosinophils.
Pfizer’s HER2-targeted therapy TUKYSA delivered a strong boost in first-line maintenance treatment for HER2-positive metastatic breast cancer, marking a major advance in today’s data from the Phase 3 HER2CLIMB-05 trial.
Zydus Lifesciences Ltd. has launched Zyrifa, a 120 mg subcutaneous biosimilar of the monoclonal antibody Denosumab. The new product increases the number of cancer patients who can receive advanced treatment of bone-care which is cheape...